연구성과로 돌아가기
JCR 2023 저널 목록 (309 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| LANDSCAPE ECOLOGY | SPRINGER | 0921-2973 | 1572-9761 | SCIE | GEOSCIENCES, MULTIDISCIPLINARY | 12,583 | 4.0 | Q1 | 15.9 | 84.1 | 41/254 | 4.9 | Q1 | 3.8 | 1.1 | 1.12 | 39/254 | Q1 | 84.84 | 0.009 | 1.893 | 1.136 | Q1 | 130 | 94.6% | 8.1 | 8.9 | 123 | 35.7% | 2025-03-24 17:16:16 | 바로가기 |
| Nuclear Science and Techniques | SPRINGER SINGAPORE PTE LTD | 1001-8042 | 2210-3147 | SCIE | PHYSICS, NUCLEAR | 2,708 | 3.6 | Q1 | 15.9 | 84.1 | 4/22 | 2.4 | Q2 | 2.3 | 0.9 | 1.42 | 3/22 | Q1 | 88.64 | 0.003 | 0.736 | 0.509 | Q2 | 190 | 99.5% | 3.3 | 7.5 | 189 | 9.1% | 2025-03-24 17:55:09 | 바로가기 |
| PLoS Computational Biology | PUBLIC LIBRARY SCIENCE | 1553-734X | 1553-7358 | SCIE | MATHEMATICAL & COMPUTATIONAL BIOLOGY | 40,134 | 3.8 | Q1 | 15.9 | 84.1 | 11/66 | 4.3 | Q1 | 3.6 | 0.6 | 1.04 | 12/66 | Q1 | 82.58 | 0.056 | 12.392 | 1.835 | Q1 | 637 | 98.9% | 6.8 | 8.7 | 630 | 99.7% | 2025-03-24 17:26:54 | 바로가기 |
| RISK ANALYSIS | WILEY | 0272-4332 | 1539-6924 | SCIE | MATHEMATICS, INTERDISCIPLINARY APPLICATIONS | 11,016 | 3.0 | Q1 | 15.9 | 84.1 | 22/135 | 3.5 | Q1 | 2.6 | 0.6 | 1.07 | 27/135 | Q1 | 80.37 | 0.007 | 1.463 | 0.899 | Q1 | 160 | 97.5% | 10.8 | 6.7 | 156 | 32.1% | 2025-03-24 17:27:39 | 바로가기 |
| SOLAR ENERGY MATERIALS AND SOLAR CELLS | ELSEVIER | 0927-0248 | 1879-3398 | SCIE | PHYSICS, APPLIED | 34,252 | 6.3 | Q1 | 15.9 | 84.1 | 29/179 | 6.0 | Q1 | 5.8 | 1.4 | 1.27 | 27/179 | Q1 | 85.20 | 0.023 | 5.065 | 1.045 | Q1 | 396 | 99.0% | 6.3 | 5.5 | 392 | 11.9% | 2025-03-24 17:54:16 | 바로가기 |
| Stroke and Vascular Neurology | BMJ PUBLISHING GROUP | 2059-8688 | 2059-8696 | SCIE | CLINICAL NEUROLOGY | 2,375 | 4.4 | Q1 | 15.9 | 84.1 | 45/280 | 6.0 | Q1 | 4.3 | 0.6 | 1.57 | 25/281 | Q1 | 91.28 | 0.005 | 1.078 | 2.030 | Q1 | 78 | 92.3% | 3.8 | 6.8 | 72 | 99.6% | 2025-03-24 17:00:32 | 바로가기 |
| Applications in Energy and Combustion Science | ELSEVIER | 2666-352X | 2666-352X | ESCI | THERMODYNAMICS | 599 | 5.0 | Q1 | 16.0 | 84.0 | 13/78 | 4.8 | Q1 | 4.7 | 1.0 | 0.79 | 20/78 | Q2 | 75.00 | 0.001 | 0.164 | 0.919 | Q1 | 122 | 97.5% | 1.6 | 6.5 | 119 | 97.6% | 2025-03-24 18:13:55 | 바로가기 |
| CARBON | PERGAMON-ELSEVIER SCIENCE LTD | 0008-6223 | 1873-3891 | SCIE | CHEMISTRY, PHYSICAL | 98,707 | 10.5 | Q1 | 16.0 | 84.0 | 29/178 | 9.2 | Q1 | 9.8 | 3.1 | 1.77 | 17/178 | Q1 | 90.73 | 0.065 | 14.236 | 1.495 | Q1 | 760 | 98.6% | 5.8 | 4.9 | 749 | 9.3% | 2025-03-24 16:59:53 | 바로가기 |
| CLINICAL PHARMACOKINETICS | ADIS INT LTD | 0312-5963 | 1179-1926 | SCIE | PHARMACOLOGY & PHARMACY | 10,794 | 4.6 | Q1 | 16.0 | 84.0 | 57/354 | 5.2 | Q1 | 4.4 | 0.7 | 1.09 | 70/354 | Q1 | 80.37 | 0.007 | 1.439 | 1.418 | Q1 | 121 | 73.6% | 11.9 | 7.6 | 89 | 57.9% | 2025-03-24 17:36:16 | 바로가기 |
| CURRENT HISTORY | UNIV CALIFORNIA PRESS | 0011-3530 | 1944-785X | SSCI | INTERNATIONAL RELATIONS | 549 | 2.4 | Q1 | 16.0 | 84.0 | 27/166 | 1.3 | Q3 | 2.4 | 1.9 | 0.50 | 103/166 | Q3 | 38.25 | 0.001 | 0.129 | 0.491 | Q3 | 13 | 100.0% | 9.1 | N/A | 13 | 0.0% | 2025-03-24 17:21:25 | 바로가기 |
| ECOLOGY | WILEY | 0012-9658 | 1939-9170 | SCIE | ECOLOGY | 58,947 | 4.4 | Q1 | 16.0 | 84.0 | 32/197 | 5.5 | Q1 | 4.2 | 1.1 | 1.22 | 31/197 | Q1 | 84.52 | 0.020 | 4.501 | 1.896 | Q1 | 251 | 99.6% | 17.5 | 10.1 | 250 | 31.5% | 2025-03-24 17:04:16 | 바로가기 |
| ENVIRONMENT AND PLANNING D-SOCIETY & SPACE | SAGE PUBLICATIONS LTD | 0263-7758 | 1472-3433 | SSCI | GEOGRAPHY | 5,458 | 2.9 | Q1 | 16.0 | 84.0 | 28/172 | 5.2 | Q1 | 2.7 | 0.7 | 0.99 | 33/173 | Q1 | 81.21 | 0.006 | 1.322 | 2.447 | Q1 | 64 | 100.0% | 10.3 | 7.6 | 64 | 45.4% | 2025-03-24 17:15:49 | 바로가기 |
| European Heart Journal-Cardiovascular Pharmacotherapy | OXFORD UNIV PRESS | 2055-6837 | 2055-6845 | SCIE | CARDIAC & CARDIOVASCULAR SYSTEMS | 1,629 | 5.4 | Q1 | 16.0 | 84.0 | 36/222 | 5.1 | Q1 | 4.5 | 1.4 | 1.69 | 29/222 | Q1 | 87.16 | 0.003 | 0.743 | 1.614 | Q1 | 63 | 73.0% | 2.7 | 4.7 | 46 | 23.4% | 2025-03-24 16:58:13 | 바로가기 |
| EXPERT OPINION ON THERAPEUTIC PATENTS | TAYLOR & FRANCIS LTD | 1354-3776 | 1744-7674 | SCIE | CHEMISTRY, MEDICINAL | 4,251 | 5.4 | Q1 | 16.0 | 84.0 | 12/72 | 6.4 | Q1 | 5.3 | 1.5 | 0.85 | 30/72 | Q2 | 59.03 | 0.003 | 0.690 | 1.257 | Q1 | 54 | 11.1% | 6.3 | 5.3 | 6 | 4.1% | 2025-03-24 16:59:17 | 바로가기 |
| EXPERT OPINION ON THERAPEUTIC TARGETS | TAYLOR & FRANCIS LTD | 1472-8222 | 1744-7631 | SCIE | PHARMACOLOGY & PHARMACY | 6,050 | 4.6 | Q1 | 16.0 | 84.0 | 57/354 | 6.3 | Q1 | 4.5 | 0.6 | 0.80 | 125/354 | Q2 | 64.83 | 0.005 | 1.025 | 1.557 | Q1 | 93 | 23.7% | 7.5 | 6.9 | 22 | 13.8% | 2025-03-24 17:36:21 | 바로가기 |
페이지 이동: